Drug
Peficitinib
Peficitinib: highest development phase Phase 3, developed by Astellas. 2 trial records tracked on RxWires.
- Highest phase
- Phase 3
- Developer
- Astellas
Trials
| Drug | Phase | Indication |
|---|---|---|
| Peficitinib NCT03660059 | Phase 3 | Rheumatoid Arthritis (RA) |
| peficitinib NCT04143477 | Phase 1 | Healthy Volunteers |
Latest
No recent events.
Follow Peficitinib on RxWires to get trial status changes, FDA actions, filings and patent dates as they happen.
Sourced from ClinicalTrials.gov, openFDA, SEC EDGAR and the FDA Orange Book. Not investment or medical advice.